Supply Chain

Here are six articles Becker's Hospital Review published in the last week, highlighting why drugmakers would welcome Amazon's pharmacy market entrance and Merck's $135M sales loss attributed to the NotPetya cyberattack.

Here are the three latest drugs approved by the Food and Drug Administration since Oct. 23.

EpiPen failures — specifically their inability to deploy correctly — were linked to seven patient deaths so far this year, according to FDA reports obtained by Bloomberg.

HHS' Office of the Assistant Secretary for Preparedness and Response activated its Emergency Prescription Assistance Program to help uninsured U.S. Virgin Island residents recovering from Hurricane Maria obtain the critical prescription medications they need.

Medline will purchase Centurion Medical Products for an undisclosed amount, the company said Wednesday.

Rumors of Amazon's potential entrance into the pharmacy market have already sent drug distributors' and retail pharmacies' stock falling. However, the drug industry would gladly welcome the move, according to CNBC.

Medicaid beneficiaries in Idaho will no longer receive nonemergency medical transportation through Veyo, an Uber-like rideshare organization.

While many organizations are stuck in “the way it’s always been,” some health systems, like Franciscan Health, are discovering the benefits of getting everybody involved in improvement.

The FDA approved AstraZeneca's new treatment for adults with a rare, but fast-growing, type of non-Hodgkin lymphoma.

Potential drug shortages spurred by supply chain disruptions in Puerto Rico most captured the attention of readers in October.